These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 37146127)

  • 61. Immunogenicity and safety of a booster dose of a self-amplifying RNA COVID-19 vaccine (ARCT-154) versus BNT162b2 mRNA COVID-19 vaccine: a double-blind, multicentre, randomised, controlled, phase 3, non-inferiority trial.
    Oda Y; Kumagai Y; Kanai M; Iwama Y; Okura I; Minamida T; Yagi Y; Kurosawa T; Greener B; Zhang Y; Walson JL
    Lancet Infect Dis; 2024 Apr; 24(4):351-360. PubMed ID: 38141632
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination.
    Haaf P; Kuster GM; Mueller C; Berger CT; Monney P; Burger P; Stämpfli SF; Attenhofer Jost CH; Zellweger MJ; Osswald S; Donner BC; Koestner SC; Tanner FC
    Swiss Med Wkly; 2021 Oct; 151():w30087. PubMed ID: 34668687
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.
    Patone M; Mei XW; Handunnetthi L; Dixon S; Zaccardi F; Shankar-Hari M; Watkinson P; Khunti K; Harnden A; Coupland CAC; Channon KM; Mills NL; Sheikh A; Hippisley-Cox J
    Nat Med; 2022 Feb; 28(2):410-422. PubMed ID: 34907393
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
    Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
    BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia.
    Jarisch A; Wiercinska E; Huenecke S; Bremm M; Cappel C; Hauler J; Rettinger E; Soerensen J; Hellstern H; Klusmann JH; Ciesek S; Bonig H; Bader P
    Transplant Cell Ther; 2022 Jul; 28(7):366.e1-366.e7. PubMed ID: 35472554
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Immune features revealed by single-cell RNA and single-cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID-19 booster vaccination.
    Fan Y; Huang S; Wu D; Chu M; Zhao J; Zhang J; Wang Y; Gui Y; Ye X; Wang G; Geng Y; Wang Y; Zhang Z
    J Med Virol; 2024 Apr; 96(4):e29573. PubMed ID: 38566569
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Imaging Acute and Chronic Cardiac Complications of COVID-19 and after COVID-19 Vaccination.
    Sánchez Tijmes F; Marschner CA; de Matos JFRG; Urzua Fresno CM; Gutiérrez Chacoff JM; Thavendiranathan P; Fuss C; Hanneman K
    Radiographics; 2023 Sep; 43(9):e230044. PubMed ID: 37616171
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Humoral and Cellular Immune Response to Covid-19 Vaccination in Patients with Chronic Graft-versus-Host Disease on Immunosuppression.
    Manjappa S; Phi HQ; Lee LW; Onstad L; Gill DB; Connelly-Smith L; Krakow EF; Flowers ME; Carpenter PA; Hill JA; Lee SJ
    Transplant Cell Ther; 2022 Nov; 28(11):784.e1-784.e9. PubMed ID: 36058550
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial.
    Chen GL; Li XF; Dai XH; Li N; Cheng ML; Huang Z; Shen J; Ge YH; Shen ZW; Deng YQ; Yang SY; Zhao H; Zhang NN; Zhang YF; Wei L; Wu KQ; Zhu MF; Peng CG; Jiang Q; Cao SC; Li YH; Zhao DH; Wu XH; Ni L; Shen HH; Dong C; Ying B; Sheng GP; Qin CF; Gao HN; Li LJ
    Lancet Microbe; 2022 Mar; 3(3):e193-e202. PubMed ID: 35098177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients.
    Enssle JC; Campe J; Moter A; Voit I; Gessner A; Yu W; Wolf S; Steffen B; Serve H; Bremm M; Huenecke S; Lohoff M; Vehreschild M; Rabenau HF; Widera M; Ciesek S; Oellerich T; Imkeller K; Rieger MA; von Metzler I; Ullrich E
    Leukemia; 2024 Jan; 38(1):168-180. PubMed ID: 38049509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of SARS-CoV-2 mRNA-Vaccine on the Induction of Myocarditis in Different Murine Animal Models.
    Zirkenbach VA; Ignatz RM; Öttl R; Cehreli Z; Stroikova V; Kaya M; Lehmann LH; Preusch MR; Frey N; Kaya Z
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902442
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk of myocarditis and pericarditis in mRNA COVID-19-vaccinated and unvaccinated populations: a systematic review and meta-analysis.
    Alami A; Krewski D; Farhat N; Mattison D; Wilson K; Gravel CA; Farrell PJ; Crispo JAG; Haddad N; Perez-Lloret S; Villeneuve PJ
    BMJ Open; 2023 Jun; 13(6):e065687. PubMed ID: 37339840
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Humoral and cellular immunity to SARS-COV-2 after vaccination with mRNA vaccines in PLWH with discordant immune response. Influence of the vaccine administered.
    López-Cortés LF; Saborido-Alconchel A; Trujillo-Rodríguez M; Serna-Gallego A; Llaves-Flores S; Muñoz-Muela E; Pérez-Santos MJ; Lozano C; Mejias-Trueba M; Roca C; Espinosa N; Gutiérrez-Valencia A
    Front Immunol; 2023; 14():1129753. PubMed ID: 37006309
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Facing COVID-19 : myocarditis following vaccination with mRNA SARS-CoV-2].
    Weerts V; Lempereur M; Léonard P; Lancellotti P
    Rev Med Liege; 2023 Mar; 78(3):141-146. PubMed ID: 36924151
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.
    Wang Y; Wang X; Luu LDW; Li J; Cui X; Yao H; Chen S; Fu J; Wang L; Wang C; Yuan R; Cai Q; Huang X; Huang J; Li Z; Li S; Zhu X; Tai J
    J Med Virol; 2022 Nov; 94(11):5304-5324. PubMed ID: 35859327
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations-A Single-Centre Retrospective Analysis.
    Wassif M; Lo P; Satouris P; Swan L; Tardo D; Kovacic JC; Muller D; Muthiah K; Kotlyar E; Bart NK
    Heart Lung Circ; 2023 Apr; 32(4):467-479. PubMed ID: 36841638
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immunological response and temporal associations in myocarditis after COVID-19 vaccination using cardiac magnetic resonance imaging: An amplified T-cell response at the heart of it?
    Vago H; Szabo L; Szabo Z; Ulakcsai Z; Szogi E; Budai G; Toth A; Juhasz V; Dohy Z; Hoffer K; Becker D; Kiss RG; Nagy GG; Nagy G; Merkely B
    Front Cardiovasc Med; 2022; 9():961031. PubMed ID: 36186968
    [TBL] [Abstract][Full Text] [Related]  

  • 79. SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
    Zedan HT; Smatti MK; Al-Sadeq DW; Al Khatib HA; Nicolai E; Pieri M; Bernardini S; Hssain AA; Taleb S; Qotba H; Issa K; Abu Raddad LJ; Althani AA; Nasrallah GK; Yassine HM
    J Med Virol; 2024 Mar; 96(3):e29527. PubMed ID: 38511514
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.